Biotechnology

FDA Grants Orphan Drug Designation to XW Laboratories' XWL-008 for the Treatment of Patients with Narcolepsy

WUHAN, China, June 24, 2019 /PRNewswire/ -- XW Laboratories Inc. (XW Labs), a clinical-stage biopharmaceutical company pioneering the discovery of novel small molecule therapeutics for the treatment of neurological disorders, today announced that the U.S. Food and Drug Administration (FDA) has gr...

2019-06-24 17:00 466

Asieris Announces Completion of Enrollment for its US APL-1202 Phase Ib Clinical Trial

SHANGHAI, June 24, 2019 /PRNewswire/ -- Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, announced today the completion of enrollment for its APL-1202 Phase Ib trial in the US....

2019-06-24 09:00 473

Gracell Data on Multi-center Investigation of FasT CAR-19 Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

- Preliminary data shows a high response rate, with 16 of 16 patients achieving complete remission and 14 of 16 patients achieving undetectable minimal residual disease with mild side effect observed - FasT CAR-19 (GC007F) can be manufactured overnight with 100% success - FasT CAR-19 is expecte...

2019-06-21 08:00 1022

SPIE To Acquire Photonex, UK's Top Photonics Exhibition

BELLINGHAM, Washington and CARDIFF, Wales, June 21, 2019 /PRNewswire/ -- SPIE, the international society for optics and photonics,has agreed to purchase Xmark Media, organizer of key UK photonics exhibitions. The acquisition expands SPIE activities inEurope, where its technical events are support...

2019-06-21 05:42 1714

Definiens & Targos Innovation: AI-powered multiplex IHC biomarker analytic solutions for precision medicine

Collaboration to bolster end-to-end services from assay development to confident informed clinical decision making MUNICH and KASSEL, Germany, June 20, 2019 /PRNewswire/ -- Definiens, a leading international Artificial Intelligence (AI)–based biomarker analysis and advanced data mining provider ...

2019-06-20 20:00 1225

First-ever successful mind-controlled robotic arm without brain implants

PITTSBURGH, June 20, 2019 /PRNewswire/ -- A team of researchers from Carnegie Mellon University, in collaboration with the University of Minnesota, has made a breakthrough in the field of noninvasive robotic device control. Using a noninvasive brain-computer interface (BCI), researchers have deve...

2019-06-20 02:05 1214

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2019

Added 22,194 New Subscribers in 4Q19 4Q19 Revenues Increased by 8.0% YoY to RMB251.7 Million ($37.5 Million) 4Q19 Operating Income Increased to RMB88.9 Million ($13.2 Million) Conference Call to be Held on June 19, 2019 at 8:00 a.m. ET HONG KONG, June 19, 2019 /PRNewswire/ -- Global Cord Blood Corp...

2019-06-19 04:16 6406

Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at 2019 ASCO and EHA Annual Meetings

SUZHOU, China, June 18, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the clinical results of CT103A, the potential best-in-class therapy of fully-human ...

2019-06-18 08:00 2749

Avalon GloboCare President and CEO David Jin, M.D., Ph.D. to Chair the "Research and Application of Stem Cell Exosomes" Session at This Year's Second International Aesthetic Industry Conference

Avalon GloboCare to Unveil the Launch of its Exosome Product Commercialization Plan at the Second Aesthetic Industry Conference, the Largest Aesthetics Conference Across Asia Yu Zhou, M.D., Ph.D., Co-CEO of Avalon's subsidiary GenExosome Technologies to provide keynote address FREEHOLD, New Jer...

2019-06-13 20:00 6705

AlpVision to Offer the First Online Biological Neural Networks (BNN) Servers Subscription Services for Artificial Intelligence Researchers

VEVEY, Switzerland, June 12, 2019 /PRNewswire/ -- AlpVision SA, a pioneering information and communication technology company and a global leader in advanced signal processing applications, announces at the AI summit inLondon the release plan of bioserver.net, a new cloud computing service based ...

2019-06-12 15:00 1328

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results

HONG KONG, June 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the fourth quarter and full year fiscal 2019 onTuesday, June 18, 2019, after the market close.  The Company will host a conference call...

2019-06-11 19:00 12189

Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device

PLYMOUTH MEETING, Pennsylvania, June 10, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that the medical arm of the U.S. Defense Threat Reduction Agency (DTRA) will fund the further development of Inovio's new commercial intradermal delivery device. DTRA's Medical ...

2019-06-10 21:00 1515

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal l...

2019-06-06 18:00 14950

Cellenkos, Inc. Initiates Phase 1 Clinical Trial of CK0801 for Treatment of Bone Marrow Failure Syndromes

HOUSTON, June 4, 2019 /PRNewswire/ -- Cellenkos, Inc., announced today the initiation of a Phase 1 Clinical Trial of CK0801, a first-in-class, allogeneic cord blood-derived T-regulatory cell product, for treatment of patients with bone marrow failure syndromes, including aplastic anemia, hypoplas...

2019-06-04 21:17 2836

Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company

HONG KONG, June 4, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors has received a no...

2019-06-04 20:17 14326

Genecare partners with Jupiter Chain to release a secure online genetic profiling platform

SINGAPORE, June 4, 2019 /PRNewswire/ -- Genetics testing is the core of preventive healthcare. Clients must first understand their genetic makeup to lower the risks of developing an illness or disease. A leading ASEAN company, Genecare, is one genetics testing company that allows clients to bette...

2019-06-04 09:00 2107

Innovent Provides Update on ctDNA in Predicting Response and Resistance by Anti-PD-1 Therapy in Chinese Relapsed/Refractory Classical Hodgkin Lymphoma

SUZHOU, China, June 3, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the results of circulating tumor DNA (ctDNA) for predicting response and resistance ...

2019-06-04 08:00 2009

Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC)

SUZHOU, China, June 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the preliminary results of efficacy and safety of sintilimab, the anti-PD-1 antibody...

2019-06-04 08:00 8417

Frost & Sullivan Publishes Q1 Update on Kadimastem

Continues its plans as expected; Ministry of Health approval for central experiment; financing is required to continue operations at the beginning of 2020; received Orphan Drug Designation from the FDA; target price unchanged. TEL AVIV, Israel, June 3, 2019 /PRNewswire/ -- The TASE analysis proje...

2019-06-03 21:24 1158

Chung Yuan Christian University plans to lead delegation of Taiwanese startups eyeing Australian market

TAIPEI, Taiwan, June 3, 2019 /PRNewswire/ -- The Innovation & Incubation Center (IAIC), an arm of the Executive Operation Office for Industry-Academia Cooperation at Chung Yuan Christian University (CYCU) hosted the International Venture Capital Investment Match event onMay 27, 2019. Over 10 inte...

2019-06-03 10:24 2613
12345 ... 47